An analysis of China's national essential medicines policy.
about
Effects of the performance management information system in improving performance: an empirical study in Shanghai Ninth People's HospitalEvaluation, in three provinces, of the introduction and impact of China's National Essential Medicines SchemePopularity and customer preferences for over-the-counter Chinese medicines perceived by community pharmacists in Shanghai and Guangzhou: a questionnaire survey study.Analysis of government investment in primary healthcare institutions to promote equity during the three-year health reform program in China.Application of propensity scores to estimate the association between government subsidy and injection use in primary health care institutions in ChinaThe effect of the National Essential Medicines Policy on health expenditures and service delivery in Chinese township health centres: evidence from a longitudinal study.Health system reforms, violence against doctors and job satisfaction in the medical profession: a cross-sectional survey in Zhejiang Province, Eastern China.Measuring access to medicines: a survey of prices, availability and affordability in Shaanxi province of China.Uptake of new antidiabetic medications in three emerging markets: a comparison between Brazil, China and Thailand.Evaluation of the implementation outcomes of the Essential Medicines System in Anhui county-level public hospitals: a before-and-after study.Urban-rural inequality regarding drug prescriptions in primary care facilities - a pre-post comparison of the National Essential Medicines Scheme of China.Current perspectives on China's national essential medicine system: primary care provider and patient views.Financial protection of rural health insurance for patients with hypertension and diabetes: repeated cross-sectional surveys in rural China.Short-term differences in drug prices after implementation of the national essential medicines system: A case study in rural Jiangxi Province, China.Factors to consider in developing individual pharmaceutical product quality risk profiles useful to government procurement agencies.International publication trends and collaboration performance of China in healthcare science and services researchJob satisfaction and associated factors among healthcare staff: a cross-sectional study in Guangdong Province, China.The relationship between job satisfaction, work stress, work-family conflict, and turnover intention among physicians in Guangdong, China: a cross-sectional study.Perceived impacts of the national essential medicines system: a cross-sectional survey of health workers in urban community health services in China.The effect of essential medicines programme on rational use of medicines in China.Distribution of essential medicines to primary care institutions in Hubei of China: effects of centralized procurement arrangements.Effects of China's national essential medicines policy on the use of injection in primary health facilities.The impact of the government health funding on prescribing behaviors in community health institutions in China.The impacts of implementation of National Essential Medicines Policies on primary healthcare institutions: a cross-sectional study in China.Effects on the medical revenue of comprehensive pricing reform in Chinese urban public hospitals after removing drug markups: case of Nanjing.China's health care system reform: Progress and prospects.Effects of prescription restrictive interventions on antibiotic procurement in primary care settings: a controlled interrupted time series study in China.Availability, use, and affordability of medicines in urban China under universal health coverage: an empirical study in Hangzhou and Baoji.Effects of County Public Hospital Reform on Procurement Costs and Volume of Antibiotics: A Quasi-Natural Experiment in Hubei Province, China.Study on essential drug use status and its influencing factors among cerebral infarction inpatients in county level hospitals of Anhui Province, China.Comparative Analysis of ADR on China's National Essential Medicines List (2015 Edition) and WHO Model List of Essential Medicines (19th Edition).
P2860
Q30380843-8425D669-600E-433C-A1CB-7A0DFA9AF80FQ30394141-7838B007-986C-4BD6-92DC-346F94330E6EQ34213273-D11AAD0C-09A4-4302-9044-3EFD837B9C25Q34636415-423CC4AC-B5A3-4FCE-B1AA-D11C30470A9EQ34729103-89003383-CDDE-4BCB-9638-2EAF44331C55Q34767907-B90BC90D-03D1-4EBC-AB3B-F574D8B18867Q34799709-B92C0318-729A-48E3-8759-46F601398579Q34926238-AF045887-151A-4F59-8E00-2B90BBF97503Q35128657-05D100C4-FEA4-42FF-BD61-BE30523A1676Q35783822-9C1C6B53-919C-49C5-8826-2710BD909A0CQ35899399-C996EE6D-2803-42E3-B676-17AD7085F7A8Q35905241-0CB8129D-EDFD-4CAA-94CB-4039E3064F12Q36127279-2CD369B7-9991-4EEC-A340-DACA62EDB776Q36210112-0F53E31A-7CE9-4DF4-9B10-31B795A6C727Q36495488-FF8B49C3-8BF1-44DF-984B-16B1818AF10FQ36521574-A25D79A7-334E-4F0A-B056-A02418E5D542Q37133980-24D357B4-0288-4AFA-A61B-21454C5E05F1Q38787532-6E97E0DC-1B20-498E-9F03-3D190591034EQ40485574-2D4EED4A-8281-4912-82D3-B1C3857A0E16Q41139474-23EC5808-39B2-476D-9276-13403BEC85AEQ44073239-C80EA638-BB9C-4A67-A677-20DBCE8E17C5Q45340391-97C7858A-0A55-4ABC-AFE7-EC7BBBA1FB6EQ47106439-8446F822-A924-4549-A52F-5C13224D7ABAQ47110349-7FB7A661-5242-4204-B083-1FC1744889A8Q47594303-E2C05B3A-C145-4DBC-A75F-63999C68AACEQ47823827-7C822A42-BC16-4A81-AC87-C904A5D49D3FQ49679204-96C95CC5-01FE-4C69-9677-50325E4A8C22Q51758956-20ABFE32-D259-492F-8610-7715C5148F23Q52578763-35AE5616-2E9C-4264-8D86-7048933BC0EFQ52604643-824F1048-BD78-4325-8BC4-BF3CAE70F75BQ55450550-B5DEB441-2085-4699-B096-483C89CE7A56
P2860
An analysis of China's national essential medicines policy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 26 May 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
An analysis of China's national essential medicines policy.
@en
An analysis of China's national essential medicines policy.
@nl
type
label
An analysis of China's national essential medicines policy.
@en
An analysis of China's national essential medicines policy.
@nl
prefLabel
An analysis of China's national essential medicines policy.
@en
An analysis of China's national essential medicines policy.
@nl
P2093
P2860
P356
P1476
An analysis of China's national essential medicines policy.
@en
P2093
Huigang Liang
Yajiong Xue
P2860
P2888
P304
P356
10.1057/JPHP.2011.34
P577
2011-05-26T00:00:00Z
P6179
1020506708